Pay in 4 interest-free payments of $6.34 Learn more
Ships within 48 hours · Estimated delivery Jul 28 - Aug 2
It shows high production efficiency and each step is carried out in accordance with GMP's regulation
Your clinician will answer questions, review your wellness history and help you understand how NAD+ may fit into your overall plan
Originally developed at Monash University as part of research into the lipolytic domain of hGH, AOD-9604 retains many of the fat-mobilising characteristics of full-length growth hormone while lacking the broader growth-promoting and insulin-resistance effects associated with the parent molecule
WADA Prohibition The World Anti-Doping Agency explicitly prohibits AOD-9604 for competitive athletes: Listed under Section S0 (Non-Approved Substances) and S2.2.3 (Growth Hormone Fragments) Prohibited at all times (both in-competition and out-of-competition) No Therapeutic Use Exemptions (TUEs) available Detection methods developed and implemented in anti-doping laboratories worldwide WADAs 2013 statement clarified that AOD-9604 is a substance still under pre-clinical and clinical development and has not been approved for therapeutic use by any government health authority in the world. Research Classification: AOD-9604 is available only for laboratory research use
US$ 27.65
US$ 24.73
US$ 29.10
US$ 22.78
US$ 21.71
US$ 27.59
US$ 27.20
US$ 24.40
US$ 21.05
US$ 25.86
US$ 24.90
US$ 22.65
US$ 21.22
US$ 22.45
US$ 28.32